Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Fantini

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|April 29, 2015
In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatmentMassimo Fantini, Monica Benvenuto, Laura Masuelli, et al.
Cancers|July 9, 2022
Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human CarcinomasKwong Yok Tsang, Massimo Fantini, Sharon A Mavroukakis, et al.
Recent Patents on Anti-Cancer Drug Discovery|May 29, 2012
Carcinoembryonic antigen (CEA)-based cancer vaccines: recent patents and antitumor effects from experimental models to clinical trialsMario Turriziani, Massimo Fantini, Monica Benvenuto, et al.
Cancer Immunology Research|May 28, 2015
Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor CellsBenjamin Boyerinas, Caroline Jochems, Massimo Fantini, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 14, 2020
The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint PathwayMassimo Fantini, Justin M David, Christina M Annunziata, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 3, 2019
An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma CellsMassimo Fantini, Justin M David, Hing C Wong, et al.
Journal of Virological Methods|July 4, 2014
Rapid molecular detection and genotyping of West Nile Virus lineages 1 and 2 by real time PCR and melting curve analysisGiovanni Faggioni, Riccardo De Santis, Alice Pomponi, et al.
Cancers|October 27, 2022
Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201Kwong Y Tsang, Massimo Fantini, Anjum Zaki, et al.
Oncology Letters|June 18, 2016
Potassium increases the antitumor effects of ascorbic acid in breast cancer cell lines <i>in vitro</i>Giovanni Vanni Frajese, Monica Benvenuto, Massimo Fantini, et al.
Oncology Letters|February 26, 2026
Erratum: [Corrigendum] Potassium increases the antitumor effects of ascorbic acid in breast cancer cell lines <i>in vitro</i>Giovanni Vanni Frajese, Monica Benvenuto, Massimo Fantini, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|April 29, 2015
In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatmentMassimo Fantini, Monica Benvenuto, Laura Masuelli, et al.
Cancers|July 9, 2022
Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human CarcinomasKwong Yok Tsang, Massimo Fantini, Sharon A Mavroukakis, et al.
Recent Patents on Anti-Cancer Drug Discovery|May 29, 2012
Carcinoembryonic antigen (CEA)-based cancer vaccines: recent patents and antitumor effects from experimental models to clinical trialsMario Turriziani, Massimo Fantini, Monica Benvenuto, et al.
Cancer Immunology Research|May 28, 2015
Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor CellsBenjamin Boyerinas, Caroline Jochems, Massimo Fantini, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 14, 2020
The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint PathwayMassimo Fantini, Justin M David, Christina M Annunziata, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 3, 2019
An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma CellsMassimo Fantini, Justin M David, Hing C Wong, et al.
Journal of Virological Methods|July 4, 2014
Rapid molecular detection and genotyping of West Nile Virus lineages 1 and 2 by real time PCR and melting curve analysisGiovanni Faggioni, Riccardo De Santis, Alice Pomponi, et al.
Cancers|October 27, 2022
Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201Kwong Y Tsang, Massimo Fantini, Anjum Zaki, et al.
Oncology Letters|June 18, 2016
Potassium increases the antitumor effects of ascorbic acid in breast cancer cell lines <i>in vitro</i>Giovanni Vanni Frajese, Monica Benvenuto, Massimo Fantini, et al.
Oncology Letters|February 26, 2026
Erratum: [Corrigendum] Potassium increases the antitumor effects of ascorbic acid in breast cancer cell lines <i>in vitro</i>Giovanni Vanni Frajese, Monica Benvenuto, Massimo Fantini, et al.
Pageof 5